Regencell Bioscience Stock (NASDAQ: RGC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 4.278K |
Day Range | - - - |
52 Wk Range | 3.160 - 30.490 |
Market Cap | $66.366M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regencell Bioscience (NASDAQ: RGC) through any online brokerage.
Other companies in Regencell Bioscience’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
The latest price target for Regencell Bioscience (NASDAQ: RGC) was reported by B. Riley Securities on Tuesday, January 2, 2018. The analyst firm set a price target for 0.00 expecting RGC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Regencell Bioscience (NASDAQ: RGC) is $5.7 last updated April 23, 2024 at 3:53 PM EDT.
A quarterly cash dividend of $0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on February 26, 2018 to stockholders of record on February 16, 2018.
Regencell Bioscience’s H1 earnings are confirmed for Thursday, June 13, 2024.
There is no upcoming split for Regencell Bioscience.
Regencell Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.